On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and ...

ORLANDO, FL / ACCESS Newswire / April 20, 2026 / RedChip Companies, an industry leader in investor relations, media, ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...

Vir Biotechnology might be on its way to becoming a major player in the market for cancer drugs if Tuesday’s stock reaction is any indication. The San Francisco-based company has been publicly traded ...

We used stock screeners to make a list of biotech stocks under $20 and picked 8 stocks with the highest number of hedge fund ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Small caps continue to have attractive valuations heading into 2026. Compared to large caps on a relative basis, small caps are significantly cheaper today than they were in most time periods. It is ...

Small caps have started holding up better than many large-cap benchmarks, but this is not a blind rush into everything below ...

ORLANDO, FL / ACCESS Newswire / April 21, 2026 / RedChip Companies, an industry leader in investor relations, media, ...